![Peter DeMuth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter DeMuth
Technik-/Wissenschafts-/F&E-Leiter bei
ELICIO THERAPEUTICS, INC.
Vermögen: 8 500 $ am 31.05.2026
Profil
Peter DeMuth currently works at Elicio Therapeutics, Inc., as Chief Scientific Officer from 2022.
Dr. DeMuth also formerly worked at Elicio Therapeutics, Inc. (United States), as Chief Scientific Officer from 2022 to 2023.
Dr. DeMuth received his doctorate degree in 2013 from Massachusetts Institute of Technology and undergraduate degree in 2008 from the University of Maryland.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.04.2026 | 743 ( 0% ) | 8 500 $ | 31.05.2026 |
Aktive Positionen von Peter DeMuth
| Unternehmen | Position | Beginn |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
Ehemalige bekannte Positionen von Peter DeMuth
| Unternehmen | Position | Ende |
|---|---|---|
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2023 |
Ausbildung von Peter DeMuth
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
